Shanghai Tongji Hospital, Tongji University School Of Medicine

This early-phase study tests a new cell therapy called TH-CART-027 in 21 adults with recurrent or progressive grade 4 glioma, a fast-growing brain cancer. The treatment uses specially engineered immune cells to attack the tumor. The main goals are to check safety and see if the t…